IP Verse

Argentum Pharmaceuticals competitive analysis

Latest PTAB cases involving Argentum Pharmaceuticals

Discover the latest PTAB cases involving Argentum Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Jul 13, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Argentum Pharmaceuticals

IPR2018-00423Jan 5, 2018ARGENTUM PHARMACEUTICALSMERCK PATENTGESELLSCHAFT MIT BESCHRANKTER HAFTUNGInstitution Denied
IPR2018-00080Oct 20, 2017ARGENTUM PHARMACEUTICALSCOSMOTerminated-Settled
IPR2018-00080Oct 20, 2017ARGENTUM PHARMACEUTICALSVILLATerminated-Settled
IPR2017-01762Jul 12, 2017ARGENTUM PHARMACEUTICALSICOSTerminated-Settled
IPR2017-01762Jul 12, 2017ARGENTUM PHARMACEUTICALSPULLMANTerminated-Settled
IPR2017-01550Jun 9, 2017ARGENTUM PHARMACEUTICALSHIESTANDFinal Written Decision
IPR2017-01550Jun 9, 2017ARGENTUM PHARMACEUTICALSNOVARTISFinal Written Decision
IPR2017-01429May 12, 2017ARGENTUM PHARMACEUTICALSKAKEN PHARMACEUTICALTerminated-Settled
IPR2017-01053Mar 10, 2017ARGENTUM PHARMACEUTICALSALCON RESEARCHFinal Written Decision
IPR2017-01053Mar 10, 2017ARGENTUM PHARMACEUTICALSKABRAFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Argentum Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 9, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ARGENTUM PHARMACEUTICALS - - 12 -
ALCON RESEARCH - 1418
CIPLA1166
NOVARTIS6470 - 21